25(OH)D (ng/mL) | Observation Period | Group I (N = 28) | Group II (N = 64) | Group III (N = 94) | Total (N = 186) |
---|---|---|---|---|---|
≥ 50.0, n (%) | Baseline | 1 (3.6) | 2 (3.1) | 1 (1.1) | 4 (2.2) |
26 weeks | 1 (3.6) | 3 (4.7) | 1 (1.1) | 5 (2.7) | |
30.0–49.9, n (%) | Baseline | 10 (35.7) | 21 (32.8) | 26 (27.7) | 57 (30.6) |
26 weeks | 15 (53.6) | 47 (73.4) | 55 (58.5) | 117 (62.9) | |
20.0–29.9, n (%) | Baseline | 14 (50.0) | 36 (56.3) | 52 (55.3) | 102 (54.8) |
26 weeks | 12 (42.9) | 14 (21.9) | 36 (38.3) | 62 (33.4) | |
< 20, n (%) | Baseline | 3 (10.7) | 5 (7.8) | 15 (16.0) | 23 (12.4) |
26 weeks | 0 (0) | 0 (0) | 2 (2.1) | 2 (1.1) | |
Mean (SD) | Baseline | 29.7 (8.8) | 29.1 (8.4) | 26.4 (10.0) | 27.8 (9.4) |
26 weeks | 33.6 (7.9) | 35.3 (7.4) | 32.4 (6.8) | 33.6 (7.3) | |
Min, Max | Baseline | 16.8, 56.1 | 14.2, 58.0 | 8.9, 102.2 | 8.9, 102.2 |
26 weeks | 22.7, 50.6 | 21.9, 58.1 | 17.2, 64.3 | 17.2, 64.3 | |
p valuea | 0.0913 | < 0.0001 | < 0.0001 | < 0.0001 |